↓ Skip to main content

Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience

Overview of attention for article published in Journal of Pharmaceutical Health Care and Sciences, May 2022
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#46 of 137)
  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience
Published in
Journal of Pharmaceutical Health Care and Sciences, May 2022
DOI 10.1186/s40780-022-00244-z
Pubmed ID
Authors

Suzan Esslinger, Linda Quinn, Sami Sampat, Marijo Otero-Lobato, Wim Noël, Anja Geldhof, Nicole Herijgers, Sarah-Jane Reeder

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Librarian 1 4%
Other 1 4%
Student > Bachelor 1 4%
Unspecified 1 4%
Other 4 17%
Unknown 10 43%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 17%
Unspecified 1 4%
Mathematics 1 4%
Nursing and Health Professions 1 4%
Computer Science 1 4%
Other 1 4%
Unknown 14 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2022.
All research outputs
#13,352,861
of 23,541,818 outputs
Outputs from Journal of Pharmaceutical Health Care and Sciences
#46
of 137 outputs
Outputs of similar age
#174,606
of 443,476 outputs
Outputs of similar age from Journal of Pharmaceutical Health Care and Sciences
#2
of 5 outputs
Altmetric has tracked 23,541,818 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 137 research outputs from this source. They receive a mean Attention Score of 3.7. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,476 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.